TrianglePUBLICATIONS · 36599114
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2023 Mar 10
- First author
- Dimopoulos MA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Dimopoulos MA
- type
- Author
- name
- Oriol A
- type
- Author
- name
- Nahi H
- type
- Author
- name
- San-Miguel J
- type
- Author
- name
- Bahlis NJ
- type
- Author
- name
- Usmani SZ
- type
- Author
- name
- Rabin N
- type
- Author
- name
- Orlowski RZ
- type
- Author
- name
- Suzuki K
- type
- Author
- name
- Plesner T
- type
- Author
- name
- Yoon SS
- type
- Author
- name
- Ben Yehuda D
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Dimopoulos MA
- type
- Author
- name
- Oriol A
- type
- Author
- name
- Nahi H
- type
- Author
- name
- San-Miguel J
- type
- Author
- name
- Bahlis NJ
- type
- Author
- name
- Usmani SZ
- type
- Author
- name
- Rabin N
- type
- Author
- name
- Orlowski RZ
- type
- Author
- name
- Suzuki K
- type
- Author
- name
- Plesner T
- type
- Author
- name
- Yoon SS
- type
- Author
- name
- Ben Yehuda D
- type
- Author
- bibliography ids
- nci-bib-30492430b72c72c5f31c91b3
- book metadata
- content sha256
- 62ce3a02ec65f9e60a8ec1edc6c1e36e04498e2a6cc44d60f22c219ad8a44932
- document type
- citation
- dois
- 10.1200/JCO.22.00940
- electronic publication date
- display
- 2023 Jan 4
- precision
- day
- year
- 2023
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:36599114
- immutable id
- pubmed:36599114@62ce3a02ec65f9e60a8ec1edc6c1e36e04498e2a6cc44d60f22c219ad8a44932
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 8
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1590-1599
- volume
- 41
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 36599114
- provenance
- batch id
- d370e99271168e8a8a13
- provider
- NCBI PubMed ESummary
- record sha256
- 5143a71b863e034897fe0b35976471d62424c89e6ea3e9010b46a054e57b7352
- response sha256
- f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
- retrieved at
- 2026-09-09T23:48:13.005737+00:00
- publication date
- display
- 2023 Mar 10
- precision
- day
- year
- 2023
- publication types
- Randomized Controlled Trial
- Multicenter Study
- Clinical Trial, Phase III
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial.
Preserved source evidence · Not medical advice